Answers are grounded in this paper and cite their sources.
Analysis shows economic burden and healthcare resource utilization of atopic dermatitis phenotypes, indicating need for tailored management strategies.
Both itch intensity and lesion severity independently and additively contributed to HCRU and economic burden of moderate-to-severe AD. Severe itch primarily increased pharmacy spending, while severe lesions drove outpatient costs. The combined phenotype of severe itch and lesions incurred the highest overall charges, underscoring the need for phenotype-informed, comprehensive AD management strategies.
No takes yet. Share an insight, caveat, or question.
Zirwas et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: